Your browser doesn't support javascript.
loading
SUPPLEMENT INDIVIDUAL ARTICLE: Skincare for Cancer Patients in Scandinavia.
J Drugs Dermatol ; 20(12): ss4-s14, 2021 Dec 01.
Article en En | MEDLINE | ID: mdl-34898158
ABSTRACT
Preventive measures, earlier diagnosis, and markedly improved anticancer treatments have resulted in increasingly more patients living with or surviving cancer. Frequently cancer treatment-related cutaneous adverse events (cAEs) occur, which can severely impact patients' quality of life (QoL) and interfere with anticancer treatment outcomes. Currently, cAEs related to anticancer treatment may be under-appreciated to prevent or provide early and effective treatment. The Nordic European Cutaneous Oncodermatology Management (NECOM) project explored clinical insights in cAEs and focused on skincare regimens involving hygiene, moisturization, sun protection, and camouflage products. The NECOM panel discussed and reached a consensus on evidence and opinion-based best practice recommendations for oncology skincare programs to support all stakeholders in the Nordic European healthcare setting working with oncology patients throughout the entire continuum of care achieve optimal outcomes, improving patients' QoL. J Drugs Dermatol. 2021;2012(Suppl)s4-14.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Drugs Dermatol Asunto de la revista: DERMATOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Drugs Dermatol Asunto de la revista: DERMATOLOGIA Año: 2021 Tipo del documento: Article